Ascension MCP Joint Replacement Approval Includes Follow-Up Requirement
This article was originally published in The Gray Sheet
Executive Summary
FDA approval of Ascension Orthopedics' metacarpophalangeal (MCP) joint replacement device opens the door for Avanta Orthopedics to file a PMA for a second alternative to silicone rubber spacers
You may also be interested in...
OPPS Pass-Through Category Needed For Ascension’s MCP and PIP – MDMA
Ascension Orthopedics' MCP and PIP total finger joint prostheses should be given a new "pass-through" category in the 2003 hospital outpatient prospective payment update, according to the Medical Device Manufacturers Association
OPPS Pass-Through Category Needed For Ascension’s MCP and PIP – MDMA
Ascension Orthopedics' MCP and PIP total finger joint prostheses should be given a new "pass-through" category in the 2003 hospital outpatient prospective payment update, according to the Medical Device Manufacturers Association
CMS Should Calculate 2003 OPPS Update Using Clinical Trial Cost Data
The dissemination of breakthrough technologies of limited market potential is hindered by the design of the hospital outpatient prospective payment system (OPPS), health consulting firm Medical Technology Partners asserts